Artelo Biosciences Inc (NASDAQ:ARTL) shares, rose in value on Thursday, April 16, with the stock price down by -1.67% to the previous day’s close as strong demand from buyers drove the stock to $0.95.
Actively observing the price movement in the last trading, the stock closed the session at $0.97, falling within a range of $0.8808 and $0.96. The value of beta (5-year monthly) was 1.167. Referring to stock’s 52-week performance, its high was $1.59, and the low was $0.82. On the whole, ARTL has fluctuated by 0.40% over the past month.
With the market capitalization of Artelo Biosciences Inc currently standing at about $3.13 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-02.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ARTL’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of ARTL currently trading nearly 3.06% and -7.90% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 50.25, while the 7-day volatility ratio is showing 21.33% which for the 30-day chart, stands at 10.02%. Furthermore, Artelo Biosciences Inc (ARTL)’s beta value is 0.94, and its average true range (ATR) is 0.10.
A comparison of Artelo Biosciences Inc (ARTL) with its peers suggests the former has fared considerably weaker in the market. ARTL showed an intraday change of -1.67% in last session, and over the past year, it shrunk by -34.22%%.
Data on historical trading for Artelo Biosciences Inc (NASDAQ:ARTL) indicates that the trading volumes over the past 10 days have averaged 2.39 and over the past 3 months, they’ve averaged 403.08K. According to company’s latest data on outstanding shares, there are 3.28 million shares outstanding.
Nearly 0.83% of Artelo Biosciences Inc’s shares belong to company insiders and institutional investors own 1.05% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1542.0 shares as on 2025-03-31, resulting in a short ratio of 0.09. According to the data, the short interest in Artelo Biosciences Inc (ARTL) stood at 5.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 1208.0. The stock has fallen by -10.02% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ARTL stock heading into the next quarter.
